Published in
American Association for the Advancement of Science, Science Translational Medicine, 383(9), 2017
DOI: 10.1126/scitranslmed.aai7866
Links
Tools
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis
Journal article published in 2017 by
Tania F. Gendron,
Jeannie Chew,
Jeannette N. Stankowski,
Lindsey R. Hayes,
Yong-Jie Zhang 
,
Mercedes Prudencio ,
Yari Carlomagno ,
Lillian M. Daughrity,
Karen Jansen-West,
Emilie A. Perkerson,
Aliesha O’Raw ,
Casey Cook,
Luc Pregent ,
Veronique Belzil ,
Marka van Blitterswijk
and other authors.
,
Mercedes Prudencio ,
Yari Carlomagno ,
Lillian M. Daughrity,
Karen Jansen-West,
Emilie A. Perkerson,
Aliesha O’Raw ,
Casey Cook,
Luc Pregent ,
Veronique Belzil ,
Marka van Blitterswijk
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Poly(GP) proteins are a promising pharmacodynamic marker for developing and testing therapeutics for treating C9ORF72 -associated amyotrophic lateral sclerosis.